Persistent pleural effusions in primary systemic amyloidosis: Etiology and prognosis

Chest

Volumn 124, Issue 3, 2003, Pages 969-977

  Berk, John L ^a,b   Keane, Joseph ^a   Seldin, David C ^a   Sanchorawala, Vaishali ^a   Koyama, Jun ^a   Dember, Laura M ^a   Falk, Rodney H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pulmonany Center   (United States)

Author keywords

Amyloid; Amyloidosis; Cardiomyopathy; Congestive heart failure; Nephrotic syndrome; Pleural effusion

Indexed keywords

AMYLOID PROTEIN; PLASMA PROTEIN;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; AUTOPSY; AUTOTRANSPLANTATION; CANCER CHEMOTHERAPY; CARDIOVASCULAR PERFORMANCE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; DIASTOLE; DIURESIS; FEMALE; HEART AMYLOIDOSIS; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE COMPLIANCE; HEART VENTRICLE FUNCTION; HEART VENTRICLE SEPTUM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN TISSUE; HYPOKINESIA; INTERMETHOD COMPARISON; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; PATIENT REFERRAL; PLASMA CELL DYSCRASIA; PLEURA BIOPSY; PLEURA EFFUSION; PLEURODESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEINURIA; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; T TUBE; THORACOCENTESIS; THYROID FUNCTION; THYROID FUNCTION TEST; TISSUE SECTION; UNIVERSITY HOSPITAL;

EID: 0141465219     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.124.3.969     Document Type: Article

References (39)

1. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995; 32:45-59
2. Berk JL, O'Regan A, Skinner M. Pulmonary and tracheobronchial amyloidosis. Semin Respir Crit Care Med 2002; 23:155-165
3. Celli BR, Rubinow A, Cohen AS, et al. Patterns of pulmonary involvement in systemic amyloidosis. Chest 1978; 74:543-547
4. Ikeda S, Takabayashi Y, Maejima Y, et al. Nodular lung disease with five year survival and unilateral pleural effusion in AL amyloidosis. Amyloid 1999; 6:292-296
5. Knapp MJ, Roggli VL, Kim J, et al. Pleural amyloidosis. Arch Pathol Lab Med 1988; 112:57-60
6. Maeno T, Sando Y, Tsukagoshi M, et al. Pleural amyloidosis in a patient with intractable pleural effusion and multiple myeloma. Respirology 2000; 5:79-80
7. Liu YY, Lee YC, Chou TY, et al. Pulmonary alveolar-septal amyloidosis presenting as heart failure with unilateral pleural effusion: a case report. Chung Hua I Hsueh Tsa Chih (Taipei) 1999; 62:838-843
8. Bontemps F, Tillie-Leblond I, Coppin MC, et al. Pleural amyloidosis: thoracoscopic aspects. Eur Respir J 1995; 8:1025-1027
9. Smith FB, Brown RB, Maguire G, et al. Localized pleural microdeposition of type A amyloid in a patient with rheumatoid pleuritis: histologic distinction from pleural involvement in systemic amyloidosis Am J Clin Pathol 1993; 99:261-264
10. Lindemalm C, Biberfeld P, Christensson B, et al. Bilateral pleural effusions due to amyloidosis in a case of Waldenström's macroglobulinemia. Haematologica 1988; 73:407-409
11. Graham DR, Ahmad D. Amyloidosis with pleural involvement. Eur Respir J 1988; 1:571-572
12. Mathews V, Vasudevan AR, Nair S, et al. Primary systemic amyloidosis: pleural involvement with exudative pleural effusion. J Assoc Physicians India 1996; 44:345-346
13. Hughes JC, Votaw ML. Pleural effusion in multiple myeloma. Cancer 1979; 44:1150-1154
14. Koyama J, Ray-Sequin PA, Davidoff R, et al. Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol 2002; 89:1067-1071
15. American Thoracic Society: Standardization of spirometry: 1987 update. Ann Rev Respir Dis 1987; 136:1285-1298
16. Dubois A, Bothelho S, Bedell G, et al. A rapid plethysomographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects. J Clin Invest 1956; 35:322-326
17. Sanchorawala V, Wright DG, Seldin DC, et al. Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis. Br J Haematol 2002; 117:886-889
18. Peto R, Peto J. Asymptotically efficient rank invariant test procedures (with discussion). J R Stat Soc [Ser A] 1972; 135:185-206
19. Light RW, Macgregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77:507-513
20. Tei C, Dujardin KS, Hodge DO, et al. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996; 28:658-664
21. Klein AL, Hatle LK, Taliercio CP, et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis: a Doppler echocardiography study. Circulation 1991; 83:808-816
22. Reisinger J, Dubrey SW, Falk RH. Cardiac amyloidosis. Cardiol Rev 1997; 5:317-325
23. Ornato JP, Lui CY, Donovan JP, et al. The difference between pulmonary artery diastolic pressure and pulmonary capillary wedge pressure as a hemodynamic sign of pulmonary embolism. Nebr Med J 1985; 70:164-167
24. Gottehrer A, Roa J, Stanford GG, et al. Hypothyroidism and pleural effusions. Chest 1990; 98:1130-1132
25. Leuallen EC, Carr DT. Pleural effusion: a statistical study of 436 patients. N Engl J Med 2002; 252:79-83
26. Dingli D, Utz JP, Gertz MA. Pulmonary hypertension in patients with amyloidosis. Chest 2001; 120:1735-1739
27. Collins TR, Sahn SA. Thoracocentesis: clinical value, complications, technical problems, and patient experience. Chest 1987; 91:817-822
28. Seneff MG, Corwin RW, Gold LH, et al. Complications associated with thoracocentesis. Chest 1986; 90:97-100
29. Mellins RB, Levine OR, Fishman AP. Effect of systemic and pulmonary venous hypertension on pleural and pericardial fluid accumulation. J Appl Physiol 1970; 29:564-569
30. Allen S, Gabel J, Drake R. Left atrial hypertension causes pleural effusion formation in unanesthetized sheep. Am J Physiol 1989; 257(suppl):H690-H692
31. Wiener-Kronish JP, Matthay MA. Pleural effusions associated with hydrostatic and increased permeability pulmonary edema. Chest 1988; 93:852-858
32. Wiener-Kronish JP, Matthay MA, Callen PW, et al. Relationship of pleural effusions to pulmonary hemodynamics in patients with congestive heart failure. Am Rev Respir Dis 1985; 132:1253-1256
33. Wiener-Kronish JP, Goldstein R, Matthay RA, et al. Lack of association of pleural effusion with chronic pulmonary arterial and right atrial hypertension. Chest 1987; 92:967-970
34. Chetty KG. Transudative pleural effusions. Clin Chest Med 1985; 6:49-54
35. Kinasewitz GT. Transudative effusions. Eur Respir J 1997; 10:714-718
36. Eid AA, Keddissi JI, Kinasewitz GT. Hypoalbuminemia as a cause of pleural effusions. Chest 1999; 115:1066-1069
37. Albertine KH, Wiener-Kronish JP, Staub NC. The structure of the parietal pleura and its relationship to pleural liquid dynamics in sheep. Anat Rec 1984; 208:401-409
38. Sanchorawala V, Wright DG, Seldin DC, et al. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant 2001; 28:637-642
39. Comenzo RL, Gertz MA. Autologous stem cell transplantation for primary systemic amyloidosis. Blood 2002; 99:4276-4282